Elsevier

The Journal of Emergency Medicine

Volume 14, Issue 1, January–February 1996, Pages 39-51
The Journal of Emergency Medicine

Paroxysmal supraventricular tachycardias

https://doi.org/10.1016/0736-4679(95)02061-6Get rights and content

Abstract

Paroxysmal supraventricular tachycardia (PSVT) is a distinct clinical syndrome. Most patients present with the abrupt onset of palpitations, dizziness, dyspnea, or chest pain. The electrocardiogram (ECG) demonstrates a fast heart rate (150–250 beats per min), a regular rhythm, and most often, a narrow QRS complex. The P wave is usually hidden within the QRS complex. PSVT is caused by reentry, and the tachycardias are classified, electrophysiologically, according to the anatomic location of the reentry circuit. Atrioventricular nodal reentry is the most common form of PSVT. In A-V nodal reentry, there are two conducting pathways (alph and beta) that have different conduction times and refractory periods; both pathways are confined to the A-V nodal and perinodal atrial tissue. The other common form of PSVT, termed atrioventricular reciprocating tachycardia, depends on an anatomically distinct, or “accessory,” pathway that may conduct impulses between the atria and the ventricles, while bypassing the AV node. The two forms of PSVT may be distinguised in many cases by examining the 12-lead electrocardiogram. In the majority of cases of A-V nodal reentry, the atria and ventricles are depolarized simultaneously, and the P waves are hidden in the QRS complex. If the reentry circuit includes an accessory pathway, the P wave always follows the QRS, and usually the R-P interval exceeds 70 msec.

Several principles should guide the management of PSVT: (a) Unstable patients require emergent electrical cardioversion; (b) A 12-lead ECG should be obtained immediately to confirm that the tachycardia has a narrow complex (ventricular tachycardia may masquerade as PSVT if only a single lead is examined); (c) Vagal maneuvers may be attempted (the Valsalva maneuver is safer and more efficacious, especially in the elderly); and (4) In most patients, adenosine is the first-line agent to treat PSVT. Contraindications to adenosine and drug interactions are noted in this article. In addition, the use of adenosine in wide complex tachycardias and the indications for admission and referral for electrophysiologic evaluation are discussed.

References (48)

  • JL McCabe et al.

    Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia

    Ann Emerg Med

    (1992)
  • Adenosine and the diagnosis of tachycardias

    Lancet

    (1992)
  • JP DiMarco et al.

    Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias

    J Am Coll Cardiol

    (1985)
  • RB Stewart et al.

    Wide complex tachycardia: misdiagnosis and outcome after emergent therapy

    Ann Intern Med

    (1986)
  • M Dancy et al.

    Misdiagnosis of chronic recurrent ventricular tachycardia

    Lancet

    (1985)
  • AC Rankin et al.

    Misuse of intravenous verapamil in patients with ventricular tachycardia

    Lancet

    (1987)
  • MJ Griffith et al.

    Adenosine in the diagnosis of broad complex tachycardia

    Lancet

    (1988)
  • AD Sharma et al.

    Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility

    Am J Med

    (1990)
  • BB Lerman et al.

    Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity

    Circulation

    (1986)
  • EL Pritchett et al.

    Clinical behavior of paroxysmal atrial tachycardia

    Am J Cardiol

    (1988)
  • AL Wit

    Cellular electrophysiologic mechanisms of cardiac arrhythmias

    Cardio Clin

    (1990)
  • BF Hoffman et al.

    Cellular mechanisms for cardiac arrhythmias

    Circ Res

    (1981)
  • D Wu

    Supraventricular tachycardias

    JAMA

    (1983)
  • MR Rosen

    The links between basic and clinical cardiac electrophysiology

    Circulation

    (1988)
  • Cited by (18)

    • “Forced inspiratory suction and swallow tool” a novel instrument to convert paroxysmal supraventricular tachycardia (SVT) to sinus rhythm, a case report and introduction of the device

      2022, American Journal of Emergency Medicine
      Citation Excerpt :

      Patients with SVT present clinically with an abrupt onset of palpitations, dizziness, dyspnea, chest pain, or syncope [4]. Patients with unstable SVT are traditionally managed with emergent electrical cardioversion, while stable patients are managed with vagal maneuvers or adenosine [1]. There are several remedies that have been described to convert the SVT, such as the Valsalva maneuver, holding the breath for a few seconds, or putting cold water on the face.

    • Paroxysmal Supraventricular Tachycardia: Pathophysiology, Diagnosis, and Management

      2016, Critical Care Nursing Clinics of North America
      Citation Excerpt :

      This normal signal propagation depends on the electrical homogeneity of adjacent conducting pathways characterized by similar refractory and conduction periods. When there are 2 separate pathways with different refractory and conduction speeds, a re-entry circuit may develop.6 PSVT is caused by re-entry and is typically classified according to the anatomic location of the re-entry circuit.

    • A prognostic index for the successful use of adenosine in patients with paroxysmal supraventricular tachycardia in emergency settings: a retrospective study

      2008, American Journal of Emergency Medicine
      Citation Excerpt :

      The other common form of PSVT, termed AV reciprocating tachycardia, depends on an anatomically distinct or “accessory” pathway that may conduct impulses between the atria and the ventricles, while bypassing the AV node. The 2 forms of PSVT may be distinguished in many cases by examining the 12-lead ECG [1]. Several principles should guide the management of PSVT:

    • Cardiovascular Agents

      2008, Pediatric Emergency Medicine
    • Cardiovascular Agents

      2007, Pediatric Emergency Medicine
    View all citing articles on Scopus

    Cardiology Commentary is coordinated by Steven R. Lowenstein, md, mph, of the University of Colorado Health Sciences Center, Denver, Colorado.

    View full text